HomeAI · summaries
Storia in 19 fonti
Moderna y Merck anuncian el éxito de la primera vacuna personalizada contra el melanoma y sus acciones se disparan en Bolsa
El avance se ha difundido en una nota de prensa en la que no se ofrecen datos concretos de mejora de supervivencia. De confirmarse, se trataría de un hito histórico
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
- ·
en.mercopress.com
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran…
